Tafamidis

Tafamidis
Product Description

Process validation will be completed in early 2025.

Shiratori Pharmaceutical

  • JP
  • 2020
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Specifications
  • Selling Points
    Process patent to reduce the impurities has been filed in Japan.
  • Supplied from
    Japan
  • Measured In
    gram

Shiratori Pharmaceutical

  • JP
  • 2020
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer

More Products from Shiratori Pharmaceutical (4)